VICPLAS INTERNATIONAL LTD (569) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of VICPLAS INTERNATIONAL LTD stock S$0.04, price S$0.06, that is 41.9% below the price, quality 44 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
VICPLAS INTERNATIONAL LTD
569 · SGFar too expensive (fair value 42% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range 0.0600 SGD – 0.2500 SGD · the 0.0620 SGD price screens above the 0.0360 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.
Every Wednesday you see whether VICPLAS INTERNATIONAL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Vicplas International Ltd, an investment holding company, engages in the medical devices, and pipes and pipe fittings businesses in Singapore, Malaysia, the People's Republic of China, the United Kingdom, and Mexico.
Show moreShow less
The company manufactures, trades, and distributes piping systems for various industries, including waste and potable water systems for residential homes, schools, and commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies.
It also designs, develops, manufactures, and assembles sterile and non-sterile medical devices. Vicplas International Ltd was founded in 1993 and is based in Singapore. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Stock analysis
VICPLAS INTERNATIONAL LTD (569) currently trades at 0.0620 SGD, while our model-based Fair Value estimate is 0.0360 SGD, 42% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Quality & growth
The Quality Score stands at 44/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
VICPLAS INTERNATIONAL LTD reported revenue of 127M SGD in FY2026 versus 114M SGD in FY2021, a compound +2.2%/yr. Reported net income was −5.1M SGD in FY2026.
Key figures
Market cap 31.7M SGD (≈ $24.6M) Micro · P/S ratio 0.25 · EPS (TTM) −0.0100 SGD · Net margin −3.9% · Return on equity −7.4% · Return on assets (EBIT) 0.1% (4-year average) · Operating margin 0.7% · Revenue (TTM) 131M SGD.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).
What moves the price
The share trades about 36% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside, at −42%, 569 screens richer than that median.
Fair Value models
All 1 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
569 screens overvalued: fair value 42% below the price. Compare with Abbott Laboratories, →
Compare VICPLAS INTERNATIONAL LTD with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 402 stocks
Valuation Multiplesvs Medical Devices median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Quality Score by industry
- Return on equity by industry
- Stock screener with 62 metrics
- Valuation of the Singapore market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Stryker Corporation SYK | $309.64 | $340.60 | +10% | vs 569 |
| Boston Scientific Corporation BSX | $44.34 | $48.77 | +10% | vs 569 |
| DexCom, Inc DXCM | $83.33 | $91.66 | +10% | vs 569 |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥184.30 | ¥197.34 | +7% | vs 569 |
| STERIS plc STE | $264.32 | $281.90 | +7% | vs 569 |
| GE HealthCare Technologies Inc GEHC | $83.02 | $69.92 | −16% | vs 569 |
| Edwards Lifesciences Corporation EW | $107.15 | $81.94 | −24% | vs 569 |
| Medtronic plc MDT | $102.86 | $74.90 | −27% | vs 569 |
| Abbott Laboratories, ABT | $108.52 | $75.28 | −31% | vs 569 |
| Koninklijke Philips N.V PHIA | €27.54 | €15.23 | −45% | vs 569 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is VICPLAS INTERNATIONAL LTD (569) overvalued or undervalued?
What is the fair value of 569?
What is the quality score of 569?
What is the price target for VICPLAS INTERNATIONAL LTD (569)?
What is the VICPLAS INTERNATIONAL LTD stock forecast for 2026?
What is the revenue of VICPLAS INTERNATIONAL LTD (569)?
What is the intrinsic value of VICPLAS INTERNATIONAL LTD (569)?
Is VICPLAS INTERNATIONAL LTD stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 569?
How much is VICPLAS INTERNATIONAL LTD worth?
How solid is the balance sheet of VICPLAS INTERNATIONAL LTD (569)?
How far is 569 from its 52-week high?
Which stocks are comparable to VICPLAS INTERNATIONAL LTD?
Is VICPLAS INTERNATIONAL LTD stock attractive at the current price?
How is the fair value of 569 calculated?
Is it still worth investing in stocks now?
What is the share price of VICPLAS INTERNATIONAL LTD (569)?
What should I pay attention to with VICPLAS INTERNATIONAL LTD right now?
Key figures of VICPLAS INTERNATIONAL LTD
How large is the market capitalisation of VICPLAS INTERNATIONAL LTD (569)?
What is the P/S ratio of VICPLAS INTERNATIONAL LTD (569)?
What are the earnings per share of VICPLAS INTERNATIONAL LTD (569)?
What is the net margin of VICPLAS INTERNATIONAL LTD (569)?
What is the return on equity of VICPLAS INTERNATIONAL LTD (569)?
What is the EBIT return on assets of VICPLAS INTERNATIONAL LTD (569)?
What is the operating margin of VICPLAS INTERNATIONAL LTD (569)?
How fast is revenue growing at VICPLAS INTERNATIONAL LTD (569)?
How fast are earnings growing at VICPLAS INTERNATIONAL LTD (569)?
How much free cash flow does VICPLAS INTERNATIONAL LTD (569) generate?
How much net debt does VICPLAS INTERNATIONAL LTD (569) carry?
Watch VICPLAS INTERNATIONAL LTD in the live analysis
One click puts VICPLAS INTERNATIONAL LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.